DERM
Journey Medical CorporationNASDAQHealthcare$4.95+6.68%ClosedMarket Cap: $121.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.81
P/S
1.96
EV/EBITDA
-27.97
DCF Value
$-8.44
FCF Yield
-10.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
59.3%
Operating Margin
-13.2%
Net Margin
-18.5%
ROE
-46.4%
ROA
-17.1%
ROIC
-14.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $16.1M | 46.3% | $-443.0K | $-1.2M | $-0.05 | — |
| FY 2025 | $61.9M | 59.3% | $-8.2M | $-11.4M | $-0.47 | — |
| Q3 2025 | $17.6M | 67.4% | $-1.5M | $-2.3M | $-0.09 | — |
| Q2 2025 | $15.0M | 60.0% | $-2.9M | $-3.8M | $-0.16 | — |
| Q1 2025 | $13.1M | 63.5% | $-3.3M | $-4.1M | $-0.18 | — |
| Q4 2024 | $13.6M | 83.6% | $2.2M | $1.5M | $0.07 | — |
| FY 2024 | $56.1M | 62.8% | $-13.7M | $-14.7M | $-0.72 | — |
| Q3 2024 | $14.6M | 63.9% | $-2.9M | $-2.4M | $-0.12 | — |
| Q2 2024 | $14.9M | 56.0% | $-2.9M | $-3.4M | $-0.17 | — |
| Q1 2024 | $13.0M | 47.7% | $-10.1M | $-10.4M | $-0.53 | — |
| Q4 2023 | $15.3M | 60.6% | $-2.1M | $-2.1M | $-0.11 | — |
| FY 2023 | $79.2M | 66.3% | $-2.1M | $-3.9M | $-0.21 | — |